Clenbuterol-induced tardive dyskinesia.
A 73-year-old man with a history of obstructive lung disease who received clenbuterol 20 mg b.i.d. over 5 years developed dyskinetic movements mainly of the respiratory muscles, closely resembling neuroleptic-induced dyskinesias. Despite drug withdrawal, abnormal movements persisted unchanged. Treatment with reserpine successfully controlled the dyskinetic movements. Clinicians should be aware of this potentially harmful effect of long-term clenbuterol therapy.
Micheli
F
F
Hospital de Clinicas José de San Martin, Neurology Department, University of Buenos Aires, Argentina.
Gatto
E
E
Gene
R
R
Pardal
M F
MF
D000368:Aged; D002976:Clenbuterol / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D008297:Male; D012110:Reserpine / Q000627:therapeutic use
D012110:Reserpine; D002976:Clenbuterol